Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus.
Eleana BollaNikolas TentolourisPetros P SfikakisMaria G G TektonidouPublished in: Lupus science & medicine (2022)
Comparable prevalence of modifiable CVRFs to RA and DM but suboptimal CVRF target achievement was observed in APS, especially in high/very high-risk patients, highlighting the need for CVRF management strategies.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- disease activity
- prognostic factors
- risk factors
- peritoneal dialysis
- interstitial lung disease
- type diabetes
- systemic lupus erythematosus
- patient reported outcomes
- glycemic control
- systemic sclerosis
- insulin resistance
- idiopathic pulmonary fibrosis
- skeletal muscle
- patient reported